Head-to-head
Found vs MEDVi
Compared on both medications across the eight dimensions this database records. They differ on 4 of those eight. Found is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Found is $289 a month all-in for tirzepatide; MEDVi is $399. Over twelve months that is $3,468 against $4,788. Value Scores are 68.7 and 57.4 out of 100.
Tirzepatide
Plan pages: Found plans · MEDVi plans
At 10 mg/week, Found is $289 a month all-in and MEDVi is $399 — $110 apart, or $1,320 across a year. Over twelve months the totals are $3,468 (billed monthly) and $4,788 (billed monthly).
Found charges a flat $289 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
MEDVi charges a flat $399 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
| Dose | Found | Rank | MEDVi | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $289 | 15/31 | $399 | 27/31 | Found by $110 |
| 5 mg | $289 | 8/17 | $399 | 15/17 | Found by $110 |
| 7.5 mg | $289 | 8/17 | $399 | 14/17 | Found by $110 |
| 10 mg | $289 | 10/27 | $399 | 21/27 | Found by $110 |
| 12.5 mg | $289 | 8/17 | $399 | 14/17 | Found by $110 |
| 15 mg | $289 | 8/17 | $399 | 14/17 | Found by $110 |
Found is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, Found sits 9 of 27 on all-in monthly cost and MEDVi sits 21. There are 11 other programs priced between them. The field median is $339 and the floor is $169, so Found is below the median and the other is above it. Found is $120 above the cheapest tirzepatide program on record. MEDVi is $230 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Found undercuts it by $160, MEDVi by $50. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Found | MEDVi | Cheaper |
|---|---|---|---|
| Month to month | $289 | $399 | Found by $110 |
| Settled dose | Found | MEDVi | Difference |
|---|---|---|---|
| 2.5 mg | $3,468 | $4,788 | $1,320 apart |
| 5 mg | $3,468 | $4,788 | $1,320 apart |
| 7.5 mg | $3,468 | $4,788 | $1,320 apart |
| 10 mg | $3,468 | $4,788 | $1,320 apart |
| 12.5 mg | $3,468 | $4,788 | $1,320 apart |
| 15 mg | $3,468 | $4,788 | $1,320 apart |
Found publishes no rate for 3-month term, 6-month term, 12-month term; MEDVi publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $3,468 on Found and $4,788 on MEDVi. Both programs charge one flat rate, so the ramp costs the same as any other stretch of the year.
Value Scores are 68.7 for Found and 57.4 for MEDVi, against a tirzepatide category floor of $169. Found leads by 11.3 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Found | 40.9 | 12.8 | 10 | 5 | 68.7 |
| MEDVi | 29.6 | 12.8 | 10 | 5 | 57.4 |
Semaglutide
Plan pages: Found plans · MEDVi plans
At 2.4 mg/week, Found is $289 a month all-in and MEDVi is $299 — $10 apart, or $120 across a year. Over twelve months the totals are $3,468 (billed monthly) and $3,588 (billed monthly).
Found charges a flat $289 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
MEDVi charges a flat $299 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Found is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 59.0 for Found and 58.0 for MEDVi, against a semaglutide category floor of $129. Found leads by 1.0 points, driven mostly by price.
Where the two programs differ
All-in monthly
Found is cheaper month to month — $289 against $399, a gap of $110 every month, or $1,320 across a year if both rates hold.
Cancellation terms
Cancellation differs: Found states Per plan terms, while MEDVi states Cancel before renewal. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Found asks for Program-based; MEDVi asks for Month-to-month. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Twelve-month cost
Over twelve months the totals are $3,468 for Found and $4,788 for MEDVi. Found is lower by $1,320 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Dose policy
Both hold one price across the whole dose ladder, so neither punishes titration and the monthly figures above are what you actually pay at 15 mg as well as at 2.5 mg.
Evidence status
Both figures carry the same evidence status, provider-stated: taken from the provider's own published pages; checkout capture pending. Neither is stronger than the other on provenance.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Found Official site
Found layers behavior-change coaching over medication access; compounded pricing lands at $289/month for tirzepatide and $289 at semaglutide maintenance (from a $169 start).
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Program-based; cancellation is Per plan terms; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — joinfound.com pricing capture 2026-08-05
Watch: Program bundles differ; confirm which plan a quoted price belongs to before comparing.
MEDVi Official site
MEDVi advertises a $179 semaglutide start that tiers to $299 at maintenance; tirzepatide is $399 flat.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — medvi.com pricing capture 2026-08-05
Watch: Start-vs-maintenance spread on semaglutide; compare on maintenance.
What neither record tells you
Found does not publish
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Most US states
- no specific cancellation or refund terms
MEDVi does not publish
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Most US states
Ask Found and MEDVi for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Neither program publishes a promotional rate with an end date, a prepaid term, or a price we have flagged for re-verification, so the comparison above is as stable as this dataset gets.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, Found Official site wins this matchup. On the structural dimensions the two are close enough that the choice comes down to availability in your state and which intake you prefer.
Both figures should be checked at the provider's own checkout before you pay. Found's tirzepatide price is provider-stated as of 2026-08-05; MEDVi's is provider-stated as of 2026-08-05.
Questions
Is Found or MEDVi cheaper for tirzepatide?
Found is cheaper on all-in monthly cost at 10 mg/week: $289 against $399, a difference of $110 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Found versus MEDVi?
Found works out to $3,468 across twelve months and MEDVi to $4,788, on the plan terms each publishes.
Does Found or MEDVi raise the price as the dose goes up?
Found: no, it charges one flat rate at every dose. MEDVi: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Found and MEDVi differ?
4 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Found and MEDVi names its pharmacy?
Neither. Found records Partner pharmacies and MEDVi records Partner pharmacies. Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the Found and MEDVi prices?
Found's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. MEDVi's is provider-stated, captured 2026-08-05. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
Found, at $289 a month all-in against $299 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: Found official site · MEDVi official site. Compounded tirzepatide and semaglutide are not FDA-approved products.